Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum Disorders

NCT03432065 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03432065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03432065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum Disorders
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2024
Completion date
August 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, autism spectrum disorder